Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f68ddaa0ddd894016af217422d657c22 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate |
2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e70bf52cd3679caa31c44188365d810 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78b4827468ef7cada0458564569aacac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e7b3c629c17b6d4ee37be5cac5dfb51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4024f9bc173f7cc6dfbdbb3ee0aa8503 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3e55c9cb07365353d303c4ba05cf86e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f378710028d2b86f129effb2731ffccb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84fbcd12a01298a5703b6afa4bcf524c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_608089347aedb95c1b666c3b7b0b73a1 |
publicationDate |
2022-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-114588265-A |
titleOfInvention |
An immunomodulator for the treatment of colorectal cancer lung metastases and a composition for prediction and detection thereof |
abstract |
The present invention relates to an immunomodulatory agent for the treatment of colorectal cancer lung metastasis and a composition for prediction and detection thereof. The immunomodulatory agent includes substances that inhibit the deletion of Bmal1 gene, and/or substances that inhibit the deletion of Per1 and Per2 genes, Compositions for predicting or detecting lung metastases from colorectal cancer include reagents for the detection of Helicobacter Helicobacter and Bacteroides lachnoclostridium, and/or reagents for the detection of the bile acid taurocholic acid. The invention affects the development process of colorectal cancer lung metastasis by regulating the tumor immune microenvironment, and predicts the risk of colorectal cancer lung metastasis by detecting the abundance of intestinal bacteria and its metabolites. |
priorityDate |
2022-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |